Cargando…
Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors
BACKGROUND: Neuroendocrine tumors are well vascularized and express specific cell surface markers, such as somatostatin receptors and the glucagon-like peptide-1 receptor (GLP-1R). Using the Rip1Tag2 transgenic mouse model of pancreatic neuroendocrine tumors (pNET), we have investigated the potentia...
Autores principales: | Wicki, Andreas, Wild, Damian, Prêtre, Vincent, Mansi, Rosalba, Orleth, Annette, Reubi, Jean-Claude, Rochlitz, Christoph, Mamot, Christoph, Mäcke, Helmut R, Christofori, Gerhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937006/ https://www.ncbi.nlm.nih.gov/pubmed/24528513 http://dx.doi.org/10.1186/2191-219X-4-9 |
Ejemplares similares
-
Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy
por: Pisarsky, Laura, et al.
Publicado: (2016) -
Spectro Auger
Publicado: (1995) -
Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications
por: Körner, Meike, et al.
Publicado: (2012) -
The potential role of podoplanin in tumour invasion
por: Wicki, A, et al.
Publicado: (2007) -
The Pierre Auger project
por: Mantsch, P M
Publicado: (1996)